RxDoctor Payments Data

Lane Bedford

Psychiatric/Mental Health · Bellaire, OHNPI 1609478015

Payments from drug & device makers

$2,613in general payments, 2019–2025

Across 142 payments — averaging $18.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$421
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$402
  • E.r. Squibb & Sons, L.L.C.$351
  • Lundbeck LLC$288
  • Teva Pharmaceuticals USA, Inc.$277
  • Otsuka America Pharmaceutical, Inc.$268
  • plus $606 from 5 others

What the payments were for

  • Food & beverage$2,601100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,613 in reported general payments places this provider in the 80th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio

Medicare billing

Part B allowed, 2024
$23,221
Medicare patients
58
Services billed
276

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl39$68,104
Abilify MaintenaAripiprazole11$30,639
Chlorpromazine Hcl42$8,154
Quetiapine Fumarate365$6,887
Paliperidone ErPaliperidone13$6,876
Oxcarbazepine88$6,431
Buspirone Hcl295$4,494
Divalproex Sodium ErDivalproex Sodium46$4,173
Clozapine40$2,849
Aripiprazole60$2,498
Ziprasidone Hcl30$1,996
Lamotrigine209$1,869
Desvenlafaxine Succinate ErDesvenlafaxine Succinate19$1,760
Duloxetine Hcl61$1,556
Benztropine Mesylate94$1,180

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$421$68,10439 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$268$30,63911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,808 psychiatric/mental health providers in Ohio.

Other psychiatric/mental health in Bellaire

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →